A 2025 report from a bipartisan, congressionally chartered commission warns that China is closing in on a win, and the United ...

Drug development in biotechnology takes time. A lot of time. On average, it takes 10 to 15 years to take a medicine from ...

Insilico Medicine has licensed TaiGen Biotechnology exclusive rights in the Greater China area to develop, commercialize, and ...

A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...

The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain ...

Greenyn Biotechnology Launches Insumate® mcIRBP-19 Bitter Melon Peptide, Targeting the Billion-Dollar Health Supplement ...

Precise Bio Inc., a Greensboro-based clinical-stage regenerative medicine company, has announced the world’s first transplant ...

Longevity Investors announces two influential private gatherings taking place during World Economic Forum (WEF) week in ...

Explore the challenges and opportunities in enhancing India's medical research ecosystem to unlock its potential for ...

Healthcare stocks as a group have not performed on par with broader equities this year. However, that doesn't mean investors ...

Data demonstrates the significant and sustained tumor regression achieved by the CAPTN-3 platform across two distinct tri-specific antibodies, IM1240 and IM1305, targeting different tumor antigens ...

Disc Medicine Inc. (NASDAQ: IRON) is one of the best biotech stocks to buy according to Wall Street analysts. On December 8, ...